Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Framing these medications as metabolic therapies helps set more realistic expectations and reinforces their role within a broader, medically guided treatment plan
Avoid GLP-1 only if you have a history of Medullary Thyroid Carcinoma (MTC) or MEN2
Dual microglia effects on blood brain barrier permeability induced by systemic inflammation
Ipamorelin is a synthetic pentapeptide growth hormone-releasing peptide (GHRP) and selective agonist of the ghrelin receptor (GHS-R1a), originally developed by Novo Nordisk in Denmark and first characterised in a landmark 1998 paper in the European Journal of Endocrinology by Raun and colleagues
Dosage is tailored to individual health needs
Your doctor may offer individualized strategies to support your transition into treatment, such as dietary recommendations and tips for managing appetite changes
